Skip to main content

Table 3 Antimicrobial resistance of E. coli in 2016–2017 in Namibia, 2016–2017

From: Antimicrobial resistance among bacteria isolated from urinary tract infections in females in Namibia, 2016–2017

 

2016 (n = 2659)

2017 (n = 2909)

Antimicrobials

No. of Resistant isolates

No. of isolates tested

%Resistant

No. of Resistant isolates

No. of isolates tested

%Resistant

Ampicillin

410

541

75.8

580

746

77.7

Amoxicillin-Clavulanic acid

153

1245

12.3

299

1551

19.3

Piperacillin/Tazobactam

4

112

3.6

7

186

3.8

Cephalothin

481

1467

32.8

564

1345

41.9

Cefuroxime

213

1186

18.0

268

1195

22.4

Ceftriaxone

83

460

18.0

73

332

22.0

Ceftazidime

15

67

22.4

8

76

10.5

Imipenem

4

470

0.9

4

713

0.6

Nalidixic acid

651

1700

38.3

671

1744

38.5

Ciprofloxacin

180

935

19.3

160

982

16.3

Ofloxacin

265

1699

15.6

290

1790

16.2

Gentamicin

309

1734

17.8

340

1819

18.7

Nitrofurantoin

163

1730

9.4

224

1803

12.4

SXT

1257

1550

81.1

1031

1336

77.2

  1. SXT: Sulfamethoxazole/Trimethoprim; %: Percentage